The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba

Detalhes bibliográficos
Autor(a) principal: Rodríguez,Antonio Pérez
Data de Publicação: 1999
Outros Autores: Dickinson,Félix, Baly,Alberto, Martinez,Ramón
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Memórias do Instituto Oswaldo Cruz
Texto Completo: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761999000400002
Resumo: The incidence of invasive meningococcal disease (IMD) before (1984-1988) and after (1989-1994), a nationwide intervention with VA-MENGOC-BC vaccination started in 1989, was compared. The prevaccination period incidence density (ID> 8.8/ 105 year-person) was higher than the postvaccination ID (ID< 6.5/ 105 year-person). The percentage proportional differences from the start to the end of each period of ID in the vaccinal period was higher (87%) than the prevaccinal (37%) with significant differences among vaccinated groups (< 25 years old). A break-point (Chow test) was confirmed by the decrease in the ID between 1989 and 1990 in children under 1 year old, 5-9, 10-14, 15-19 and 50-54 years. Comparison of ID using maps showed a decrease in IMD in all municipalities during the postvaccination period. These findings support the epidemiological impact of VA-MENGOC-BC vaccination in the reduction of IMD morbidity.
id FIOCRUZ-4_6614f26199dde84f6d078efad3a5ae38
oai_identifier_str oai:scielo:S0074-02761999000400002
network_acronym_str FIOCRUZ-4
network_name_str Memórias do Instituto Oswaldo Cruz
spelling The Epidemiological Impact of Antimeningococcal B Vaccination in Cubainvasive meningococcal diseaseimpact of vaccinationantimeningococcal B vaccinevaccine effectivenesscontrol of epidemicCubaThe incidence of invasive meningococcal disease (IMD) before (1984-1988) and after (1989-1994), a nationwide intervention with VA-MENGOC-BC vaccination started in 1989, was compared. The prevaccination period incidence density (ID> 8.8/ 105 year-person) was higher than the postvaccination ID (ID< 6.5/ 105 year-person). The percentage proportional differences from the start to the end of each period of ID in the vaccinal period was higher (87%) than the prevaccinal (37%) with significant differences among vaccinated groups (< 25 years old). A break-point (Chow test) was confirmed by the decrease in the ID between 1989 and 1990 in children under 1 year old, 5-9, 10-14, 15-19 and 50-54 years. Comparison of ID using maps showed a decrease in IMD in all municipalities during the postvaccination period. These findings support the epidemiological impact of VA-MENGOC-BC vaccination in the reduction of IMD morbidity.Instituto Oswaldo Cruz, Ministério da Saúde1999-07-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761999000400002Memórias do Instituto Oswaldo Cruz v.94 n.4 1999reponame:Memórias do Instituto Oswaldo Cruzinstname:Fundação Oswaldo Cruzinstacron:FIOCRUZ10.1590/S0074-02761999000400002info:eu-repo/semantics/openAccessRodríguez,Antonio PérezDickinson,FélixBaly,AlbertoMartinez,Ramóneng2020-04-25T17:48:10Zhttp://www.scielo.br/oai/scielo-oai.php0074-02761678-8060opendoar:null2020-04-26 02:08:58.317Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruztrue
dc.title.none.fl_str_mv The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba
title The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba
spellingShingle The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba
Rodríguez,Antonio Pérez
invasive meningococcal disease
impact of vaccination
antimeningococcal B vaccine
vaccine effectiveness
control of epidemic
Cuba
title_short The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba
title_full The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba
title_fullStr The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba
title_full_unstemmed The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba
title_sort The Epidemiological Impact of Antimeningococcal B Vaccination in Cuba
author Rodríguez,Antonio Pérez
author_facet Rodríguez,Antonio Pérez
Dickinson,Félix
Baly,Alberto
Martinez,Ramón
author_role author
author2 Dickinson,Félix
Baly,Alberto
Martinez,Ramón
author2_role author
author
author
dc.contributor.author.fl_str_mv Rodríguez,Antonio Pérez
Dickinson,Félix
Baly,Alberto
Martinez,Ramón
dc.subject.por.fl_str_mv invasive meningococcal disease
impact of vaccination
antimeningococcal B vaccine
vaccine effectiveness
control of epidemic
Cuba
topic invasive meningococcal disease
impact of vaccination
antimeningococcal B vaccine
vaccine effectiveness
control of epidemic
Cuba
dc.description.none.fl_txt_mv The incidence of invasive meningococcal disease (IMD) before (1984-1988) and after (1989-1994), a nationwide intervention with VA-MENGOC-BC vaccination started in 1989, was compared. The prevaccination period incidence density (ID> 8.8/ 105 year-person) was higher than the postvaccination ID (ID< 6.5/ 105 year-person). The percentage proportional differences from the start to the end of each period of ID in the vaccinal period was higher (87%) than the prevaccinal (37%) with significant differences among vaccinated groups (< 25 years old). A break-point (Chow test) was confirmed by the decrease in the ID between 1989 and 1990 in children under 1 year old, 5-9, 10-14, 15-19 and 50-54 years. Comparison of ID using maps showed a decrease in IMD in all municipalities during the postvaccination period. These findings support the epidemiological impact of VA-MENGOC-BC vaccination in the reduction of IMD morbidity.
description The incidence of invasive meningococcal disease (IMD) before (1984-1988) and after (1989-1994), a nationwide intervention with VA-MENGOC-BC vaccination started in 1989, was compared. The prevaccination period incidence density (ID> 8.8/ 105 year-person) was higher than the postvaccination ID (ID< 6.5/ 105 year-person). The percentage proportional differences from the start to the end of each period of ID in the vaccinal period was higher (87%) than the prevaccinal (37%) with significant differences among vaccinated groups (< 25 years old). A break-point (Chow test) was confirmed by the decrease in the ID between 1989 and 1990 in children under 1 year old, 5-9, 10-14, 15-19 and 50-54 years. Comparison of ID using maps showed a decrease in IMD in all municipalities during the postvaccination period. These findings support the epidemiological impact of VA-MENGOC-BC vaccination in the reduction of IMD morbidity.
publishDate 1999
dc.date.none.fl_str_mv 1999-07-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761999000400002
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761999000400002
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S0074-02761999000400002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
publisher.none.fl_str_mv Instituto Oswaldo Cruz, Ministério da Saúde
dc.source.none.fl_str_mv Memórias do Instituto Oswaldo Cruz v.94 n.4 1999
reponame:Memórias do Instituto Oswaldo Cruz
instname:Fundação Oswaldo Cruz
instacron:FIOCRUZ
reponame_str Memórias do Instituto Oswaldo Cruz
collection Memórias do Instituto Oswaldo Cruz
instname_str Fundação Oswaldo Cruz
instacron_str FIOCRUZ
institution FIOCRUZ
repository.name.fl_str_mv Memórias do Instituto Oswaldo Cruz - Fundação Oswaldo Cruz
repository.mail.fl_str_mv
_version_ 1669937675408244736